We found statistically significant differences between RDwCNS and MS regarding CSF cell count, the presence of OCBs and the production of intrathecal immunoglobulins, but none of these parameters was able to reliably differentiate ANA-positive MS from RDwCNS, when used exclusively. The gene discussed is BTG3; the disease is myeloid sarcoma.